Association of C4d deposition with clinical outcomes in IgA nephropathy
- PMID: 24578331
- PMCID: PMC4011455
- DOI: 10.2215/CJN.09710913
Association of C4d deposition with clinical outcomes in IgA nephropathy
Abstract
Background and objectives: Several studies have suggested that activation of the complement system is a contributing pathogenic mechanism in IgA nephropathy (IgAN). C4d staining is an inexpensive and easy-to-perform method for the analysis of renal biopsies. This study aimed to assess the clinical and prognostic implications of C4d staining in IgAN.
Design, setting, participants, & measurements: This retrospective cohort study included 283 patients with IgAN in 11 hospitals in Spain who underwent a renal biopsy between 1979 and 2010. The primary predictor was mesangial C4d staining. Secondary predictors included demographic, clinical, and laboratory characteristics, and Oxford pathologic classification criteria. The primary end point was the cumulative percentage of patients who developed ESRD, defined as onset of chronic dialysis or renal transplantation. C4d was analyzed by immunohistochemical staining using a polyclonal antibody. Kaplan-Meier and Cox proportional hazards analyses were performed to evaluate the effect of C4d staining on renal survival.
Results: There were 109 patients (38.5%) and 174 patients (61.5%) who were classified as C4d positive and C4d negative, respectively. Renal survival at 20 years was 28% in C4d-positive patients versus 85% in C4d-negative patients (P<0.001). Independent risk factors associated with ESRD were as follows: proteinuria (hazard ratio [HR] per every 1 g/d increase. 1.16; 95% confidence interval [95% CI], 1.03 to 1.31; P=0.01), eGFR (HR per every 1 ml/min per 1.73 m(2) increase, 0.96; 95% CI, 0.94 to 0.97; P<0.001), T2 Oxford classification (tubular atrophy/interstitial fibrosis, >50%; HR, 4.42; 95% CI, 1.40 to 13.88; P=0.01), and C4d-positive staining (HR, 2.45; 95% CI, 1.30 to 4.64; P=0.01).
Conclusions: C4d-positive staining is an independent risk factor for the development of ESRD in IgAN. This finding is consistent with the possibility that complement activation is involved in the pathogenesis of this disease.
Keywords: IgA nephropathy; complement; survival.
Figures
Similar articles
-
Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.Pediatr Nephrol. 2017 Jul;32(7):1211-1220. doi: 10.1007/s00467-017-3610-y. Epub 2017 Feb 23. Pediatr Nephrol. 2017. PMID: 28233100
-
Prognostic value of glomerular C4d staining in patients with IgA nephritis.Int J Clin Exp Pathol. 2014 May 15;7(6):3299-304. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25031752 Free PMC article.
-
Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.Nephrol Dial Transplant. 2009 Mar;24(3):886-91. doi: 10.1093/ndt/gfn563. Epub 2008 Oct 8. Nephrol Dial Transplant. 2009. PMID: 18842673
-
Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.Nephrology (Carlton). 2016 Dec;21(12):995-1002. doi: 10.1111/nep.12850. Nephrology (Carlton). 2016. PMID: 27414046 Review.
-
Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.Clin Transplant. 2007 Mar-Apr;21(2):159-65. doi: 10.1111/j.1399-0012.2007.00487.x. Clin Transplant. 2007. PMID: 17425739 Review.
Cited by
-
The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.Int J Mol Sci. 2024 Jan 26;25(3):1566. doi: 10.3390/ijms25031566. Int J Mol Sci. 2024. PMID: 38338844 Free PMC article. Review.
-
Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy.Kidney Int Rep. 2023 Sep 22;8(12):2515-2528. doi: 10.1016/j.ekir.2023.09.020. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106572 Free PMC article. Review.
-
Validating the association of Oxford classification and renal function deterioration among Taiwanese individuals with Immunoglobulin A nephropathy.Sci Rep. 2023 Dec 11;13(1):21904. doi: 10.1038/s41598-023-49331-7. Sci Rep. 2023. PMID: 38082065 Free PMC article.
-
Targeting complement in IgA nephropathy.Clin Kidney J. 2023 Dec 4;16(Suppl 2):ii28-ii39. doi: 10.1093/ckj/sfad198. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38053977 Free PMC article. Review.
-
Treatment of IgA Nephropathy: A Rapidly Evolving Field.J Am Soc Nephrol. 2024 Jan 1;35(1):103-116. doi: 10.1681/ASN.0000000000000242. Epub 2023 Sep 29. J Am Soc Nephrol. 2024. PMID: 37772889
References
-
- Wyatt R, Julian B: IgA nephropathy. N Engl J Med 368: 2402–2414, 2013 - PubMed
-
- Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, Olea T, Martínez-Ara J, Segarra A, Bernis C, García A, Goicoechea M, García de Vinuesa S, Rojas-Rivera J, Praga M, Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN) : Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 23: 1753–1760, 2012 - PMC - PubMed
-
- Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 347: 738–748, 2002 - PubMed
-
- Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z: Long-term renal survival and related risk factors in patients with IgA nephropathy: Results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant 27: 1479–1485, 2012 - PubMed
-
- Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D’Agati V, D’Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H, Working Group of the International IgA Nephropathy Network and the Renal Pathology Society : The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility. Kidney Int 76: 546–556, 2009 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
